60 Degrees Pharmaceuticals, Inc.
SXTP
$1.61
-$0.03-1.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.33% | 29.65% | -7.25% | 58.45% | -535.89% |
| Total Depreciation and Amortization | 54.17% | 48.43% | 55.10% | 79.09% | -23.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -168.49% | -276.91% | -52.73% | -92.08% | 111.24% |
| Change in Net Operating Assets | -780.12% | -87.85% | 39.51% | -79.16% | 393.94% |
| Cash from Operations | -71.63% | -3.31% | -25.45% | -22.04% | -40.07% |
| Capital Expenditure | -1,011.11% | -- | 27.54% | 47.44% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.24% | -61,357.14% | 99.11% | 89.16% | 17,500.00% |
| Cash from Investing | -29.89% | -65,157.14% | 98.54% | 60.41% | 17,472.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.50% | 45,760.00% | -16.76% | -100.00% | -9.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.59% | 45,760.00% | -16.85% | 100.00% | -10.84% |
| Foreign Exchange rate Adjustments | 159.60% | 30.00% | -33.33% | 1,046.67% | -1,137.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.99% | -58.76% | 24.63% | -12.63% | 138.25% |